Immundiagnostik, Inc. Partners With Epitope Diagnostics, Inc. to Offer Chemiluminescent Solutions - PR.com

▤ Summary

Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. to expand access to the ECL100 chemiluminescent analyzer and more than 50 CLIA kits across North America. The companies want to help clinical and research labs handle higher test volumes with better efficiency, lower staffing needs, and improved workflow. The ECL100 runs 120 to 180 tests per hour and supports a broad menu of assays, including new gastrointestinal markers. This partnership targets labs that need faster, more accurate testing while managing technician shortages and resource constraints.

▦ Linked Companies